Avicena signs distribution contract with RITA Company for dermaceutical compounds Avicena Group.

An interview with Professor Lesley Jones RITA is certainly highly regarded as a respected, global provider of specialty chemical substances to the aesthetic and personal care sectors , said Belinda Tsao-Nivaggioli, Ph.D., CEO of Avicena. This makes RITA a perfect partner to distribute our proprietary dermaceutical elements and to considerably increase our existing dermaceutical business. We have been excited to really have the possibility to distribute Avicena’s scientifically structured skin care elements , stated Brian Goode, President of RITA.Related StoriesHospi introduces Macy Catheter Tray at ACEP annual meetingFirst-series catheter ablation treatment superior to medication therapy for suppressing AFAngina in ladies associated with abnormal heart blood flow’The results indicate that in sufferers with an intermediate scientific probability of coronary artery disease, cardiac CT scans may avoid the use of invasive catheter angiography. Catheter-based angiography is the gold standard for coronary artery evaluation presently, but it is an invasive technique, has a little %age of ‘major’ problems and it is relatively costly,’ said Drs. Meijer and Kroft. ‘Radiologists, cardiologists, their individuals, medical policy makers and economic controllers all possess a stake in studying the accuracy and usefulness of computer generated images of the center.